| abstract |
The present invention relates to a 1-[m-carbamoyl(hetero)aryl-methyl]-heterocyclic-carbamamine compound of the formula (I), wherein X, Ar1, R1, R2, R3, R4, R5a, R5b and p are as described in the specification, their preparation, their pharmaceutically acceptable salts, and their use as pharmaceuticals, pharmaceutical compositions containing one or more compounds of formula (I), and especially as CXCR7 The use of body regulators. |